Quarterly report pursuant to Section 13 or 15(d)

REPORTABLE SEGMENTS (Details)

v2.4.0.6
REPORTABLE SEGMENTS (Details) (USD $)
 3 Months Ended 9 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Revenues $ 190,800 $ 197,800 $ 589,100 $ 537,400
Operating expenses:        
Cost of revenues 35,500 37,800 110,700 110,300
Research 66,300 77,700 203,400 408,100
Product Development 200,900 104,100 476,200 364,800
Sales and marketing 226,000 366,600 871,100 960,900
General and administrative 916,700 1,060,700 3,028,400 3,193,800
Total operating expenses 1,445,400 1,646,900 4,689,800 5,037,900
Loss from operations (1,254,600) (1,449,100) (4,100,700) (4,500,500)
Reference Neurometric [Member]
        
Revenues 38,000 33,200 113,200 106,000
Operating expenses:        
Cost of revenues 35,500 37,800 110,700 110,300
Research 66,300 77,000 203,400 408,100
Product Development 200,900 104,100 476,200 364,800
Sales and marketing 223,200 333,200 813,600 895,400
General and administrative 660,300 780,600 2,257,300 2,381,100
Total operating expenses 1,186,200 1,333,400 3,861,200 4,159,700
Loss from operations (1,148,200) (1,300,200) (3,748,000) (4,053,700)
Clinic [Member]
        
Revenues 158,000 172,800 499,100 456,000
Operating expenses:        
Cost of revenues 5,200 8,200 23,200 24,600
Research 0 0 0 0
Product Development 0 0 0 0
Sales and marketing 2,800 33,400 57,500 65,500
General and administrative 256,400 280,100 771,100 812,700
Total operating expenses 264,400 321,700 851,800 902,800
Loss from operations (106,400) (148,900) (352,700) (446,800)
Eliminations [Member]
        
Revenues (5,200) (8,200) (23,200) (24,600)
Operating expenses:        
Cost of revenues (5,200) (8,200) (23,200) (24,600)
Research 0 0 0 0
Product Development 0 0 0 0
Sales and marketing 0 0 0 0
General and administrative 0 0 0 0
Total operating expenses (5,200) (8,200) (23,200) (24,600)
Loss from operations $ 0 $ 0 $ 0 $ 0